跳至主要内容
临床试验/EUCTR2014-003331-18-AT
EUCTR2014-003331-18-AT进行中(未招募)1 期

The influence of occlusive application of 5-aminolaevulinic acid (ALA) onthe efficacy of photodynamic therapy for actinic keratosis - PDT vs PDT and translucent bandage in patients with AK

Medizinische Universität Wien, univ. Klinik f. Dermatologie0 个研究点目标入组 45 人开始时间: 2014年11月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with clinically confirmed actinic keratosis in the face and scalp
  • Age 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Known allergy to aminlevulinic acid
  • Patients with porphyria or taking photosensitizing drugs
  • Patients with severe compromised general state
  • Patients who are participating in another study
  • Patients unable to stick to the study protocol
  • Pregnant or lactating women

研究者

发起方
Medizinische Universität Wien, univ. Klinik f. Dermatologie

相似试验